Literature DB >> 18975052

Pleomorphic malignant fibrous histiocytoma: response of bone, lung, and brain metastases to chemotherapy.

Manabu Hoshi1, Masatsugu Takami, Makoto Ieguchi.   

Abstract

We present a case of pleomorphic malignant fibrous histiocytoma arising from the left forearm in a 45-year-old man who had undergone resection and radiotherapy for a tumor 3 years previously. At his first visit, he had multiple lung and bone metastases. Although these metastases responded well to systemic chemotherapy, brain metastases newly appeared and caused the death of the patient. These findings demonstrate that individual sarcomatous metastatic organs exhibit different sensitivities to chemotherapy. The mechanism of this phenomenon is discussed with a review of previous reports. It is suggested that the blood-brain barrier may play an important role in sensitivity to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18975052     DOI: 10.1007/s11604-008-0256-5

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  25 in total

1.  Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas.

Authors:  M J van den Bent; J H Schellens; C J Vecht; P A Sillevis Smit; O J Loosveld; J Ma; C C Tijssen; R L Jansen; J M Kros; J Verweij
Journal:  Eur J Cancer       Date:  1998-09       Impact factor: 9.162

2.  Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival.

Authors:  K G Billingsley; M E Burt; E Jara; R J Ginsberg; J M Woodruff; D H Leung; M F Brennan
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

3.  Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity.

Authors:  R W Gregg; J M Molepo; V J Monpetit; N Z Mikael; D Redmond; M Gadia; D J Stewart
Journal:  J Clin Oncol       Date:  1992-05       Impact factor: 44.544

4.  1995 AUR Memorial Award. Gamma knife irradiation-induced changes in the normal rat brain studied with 1H magnetic resonance spectroscopy and imaging.

Authors:  R A Omary; S S Berr; T Kamiryo; G Lanzino; N F Kassell; K S Lee; M B Lopes; B J Hillman
Journal:  Acad Radiol       Date:  1995-12       Impact factor: 3.173

Review 5.  Ifosfamide: pharmacokinetic properties for central nervous system metastasis prevention.

Authors:  F Lokiec
Journal:  Ann Oncol       Date:  2006-05       Impact factor: 32.976

6.  Prognostic factors and a scoring system for patients with skeletal metastasis.

Authors:  H Katagiri; M Takahashi; K Wakai; H Sugiura; T Kataoka; K Nakanishi
Journal:  J Bone Joint Surg Br       Date:  2005-05

7.  Modulation of doxorubicin concentration by cyclosporin A in brain and testicular barrier tissues expressing P-glycoprotein in rats.

Authors:  C S Hughes; S L Vaden; C A Manaugh; G S Price; L C Hudson
Journal:  J Neurooncol       Date:  1998-03       Impact factor: 4.130

8.  Soft tissue sarcoma brain metastases. Prevalence in a cohort of 3829 patients.

Authors:  N Joseph Espat; Mark Bilsky; Jonathan J Lewis; Denis Leung; Murray F Brennan
Journal:  Cancer       Date:  2002-05-15       Impact factor: 6.860

9.  Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases.

Authors:  L A Lanza; J B Putnam; R S Benjamin; J A Roth
Journal:  Ann Thorac Surg       Date:  1991-02       Impact factor: 4.330

Review 10.  Current therapeutic approaches in patients with brain metastases.

Authors:  Kevin H Peacock; Glenn J Lesser
Journal:  Curr Treat Options Oncol       Date:  2006-11
View more
  1 in total

Review 1.  Brain metastasis in bone and soft tissue cancers: a review of incidence, interventions, and outcomes.

Authors:  Faris Shweikeh; Laura Bukavina; Kashif Saeed; Reem Sarkis; Aarushi Suneja; Fadi Sweiss; Doniel Drazin
Journal:  Sarcoma       Date:  2014-03-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.